BridgeMD
Tests treatment safety and results for Gynecologic Disease
Official title Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
ClinicalTrials.gov ID: NCT07043322
What this study is testing
What is Cabergoline?
Cabergoline is an investigational medicine, being studied as a potential treatment for gynecologic disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of controlled ovarian stimulation of gonadotrophin-Stimulated ovarian cycles. It is theorized to manifest systemically as a result of vasoactive mediators like vascular endothelium growth factor (VEGF) being released from hyperstimulated ovaries.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 35, women only
You may be able to join if
- Age between 18-38 years
- Body mass index (calculated as weight in kilograms divided by the square of height in meters) \< 30 kg/m2.
- A long luteal protocol is used for ovarian stimulation.
- Day 2 FSH \<10 mIU/L and E2\< 50 pg/ml
- High risk of OHSS, defined as having more than 20 follicles \>12 mm in diameter and/or E2 levels \> 3000 pg/ml when the size of the leading follicle...
You likely can't join if
- The presence of chronic medical diseases, including liver cell failure, renal failure, uncontrolled hypertension, uncontrolled diabetes mellitus, or...
- Allergy to Cabergoline.
The study team makes the final eligibility decision.
Where it's taking place
- Damietta, New Damietta, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Damietta, New Damietta, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.